Your browser doesn't support javascript.
Immunologic resilience and COVID-19 survival advantage.
Lee, Grace C; Restrepo, Marcos I; Harper, Nathan; Manoharan, Muthu Saravanan; Smith, Alisha M; Meunier, Justin A; Sanchez-Reilly, Sandra; Ehsan, Aamir; Branum, Anne P; Winter, Caitlyn; Winter, Lauryn; Jimenez, Fabio; Pandranki, Lavanya; Carrillo, Andrew; Perez, Graciela L; Anzueto, Antonio; Trinh, Hanh; Lee, Monica; Hecht, Joan M; Martinez-Vargas, Celida; Sehgal, Raj T; Cadena, Jose; Walter, Elizabeth A; Oakman, Kimberly; Benavides, Raymond; Pugh, Jacqueline A; Letendre, Scott; Steri, Maristella; Orrù, Valeria; Fiorillo, Edoardo; Cucca, Francesco; Moreira, Alvaro G; Zhang, Nu; Leadbetter, Elizabeth; Agan, Brian K; Richman, Douglas D; He, Weijing; Clark, Robert A; Okulicz, Jason F; Ahuja, Sunil K.
  • Lee GC; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; Pharmacotherapy Education and Research Center, School of Medicine, University of Texas Health Science Center at San Antonio, San Anton
  • Restrepo MI; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; South Texas Veterans Health Care System, San Antonio, Tex; Department of Medicine, University of Texas Health Science Center at San An
  • Harper N; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; The Foundation for Advancing Veterans' Health Research, San Antonio, Tex.
  • Manoharan MS; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Tex.
  • Smith AM; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; The Foundation for Advancing Veterans' Health Research, San Antonio, Tex; Department of Microbiology, Immunology & Molecular Genet
  • Meunier JA; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; The Foundation for Advancing Veterans' Health Research, San Antonio, Tex.
  • Sanchez-Reilly S; South Texas Veterans Health Care System, San Antonio, Tex; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Tex.
  • Ehsan A; South Texas Veterans Health Care System, San Antonio, Tex.
  • Branum AP; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; The Foundation for Advancing Veterans' Health Research, San Antonio, Tex.
  • Winter C; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, Tex.
  • Winter L; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, Tex.
  • Jimenez F; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; The Foundation for Advancing Veterans' Health Research, San Antonio, Tex.
  • Pandranki L; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Tex.
  • Carrillo A; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; The Foundation for Advancing Veterans' Health Research, San Antonio, Tex.
  • Perez GL; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; The Foundation for Advancing Veterans' Health Research, San Antonio, Tex.
  • Anzueto A; South Texas Veterans Health Care System, San Antonio, Tex; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Tex.
  • Trinh H; South Texas Veterans Health Care System, San Antonio, Tex.
  • Lee M; South Texas Veterans Health Care System, San Antonio, Tex.
  • Hecht JM; South Texas Veterans Health Care System, San Antonio, Tex; The Foundation for Advancing Veterans' Health Research, San Antonio, Tex.
  • Martinez-Vargas C; South Texas Veterans Health Care System, San Antonio, Tex.
  • Sehgal RT; South Texas Veterans Health Care System, San Antonio, Tex; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Tex.
  • Cadena J; South Texas Veterans Health Care System, San Antonio, Tex; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Tex.
  • Walter EA; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; South Texas Veterans Health Care System, San Antonio, Tex; Department of Medicine, University of Texas Health Science Center at San An
  • Oakman K; South Texas Veterans Health Care System, San Antonio, Tex.
  • Benavides R; Pharmacotherapy Education and Research Center, School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Tex; College of Pharmacy, The University of Texas at Austin, Austin, Tex.
  • Pugh JA; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; South Texas Veterans Health Care System, San Antonio, Tex; Department of Medicine, University of Texas Health Science Center at San An
  • Letendre S; Department of Medicine, University of California, San Diego, Calif; HIV Neurobehavioral Research Center Antiviral Research Center, University of California, San Diego, Calif.
  • Steri M; Institute for Genetic and Biomedical Research, National Research Council (CNR), Sardinia, Italy.
  • Orrù V; Institute for Genetic and Biomedical Research, National Research Council (CNR), Sardinia, Italy.
  • Fiorillo E; Institute for Genetic and Biomedical Research, National Research Council (CNR), Sardinia, Italy.
  • Cucca F; Institute for Genetic and Biomedical Research, National Research Council (CNR), Sardinia, Italy; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Moreira AG; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, Tex.
  • Zhang N; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; Department of Microbiology, Immunology & Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio
  • Leadbetter E; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; Department of Microbiology, Immunology & Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio
  • Agan BK; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Md; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Md.
  • Richman DD; Department of Medicine, University of California, San Diego, Calif.
  • He W; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; The Foundation for Advancing Veterans' Health Research, San Antonio, Tex.
  • Clark RA; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; South Texas Veterans Health Care System, San Antonio, Tex; Department of Medicine, University of Texas Health Science Center at San An
  • Okulicz JF; Infectious Disease Service, San Antonio Military Medical Center, Fort Sam Houston, San Antonio, Tex.
  • Ahuja SK; Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; South Texas Veterans Health Care System, San Antonio, Tex; Department of Medicine, University of Texas Health Science Center at San An
J Allergy Clin Immunol ; 148(5): 1176-1191, 2021 11.
Article in English | MEDLINE | ID: covidwho-1401557
ABSTRACT

BACKGROUND:

The risk of severe coronavirus disease 2019 (COVID-19) varies significantly among persons of similar age and is higher in males. Age-independent, sex-biased differences in susceptibility to severe COVID-19 may be ascribable to deficits in a sexually dimorphic protective attribute that we termed immunologic resilience (IR).

OBJECTIVE:

We sought to examine whether deficits in IR that antedate or are induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection independently predict COVID-19 mortality.

METHODS:

IR levels were quantified with 2 novel metrics immune health grades (IHG-I [best] to IHG-IV) to gauge CD8+ and CD4+ T-cell count equilibrium, and blood gene expression signatures. IR metrics were examined in a prospective COVID-19 cohort (n = 522); primary outcome was 30-day mortality. Associations of IR metrics with outcomes in non-COVID-19 cohorts (n = 13,461) provided the framework for linking pre-COVID-19 IR status to IR during COVID-19, as well as to COVID-19 outcomes.

RESULTS:

IHG-I, tracking high-grade equilibrium between CD8+ and CD4+ T-cell counts, was the most common grade (73%) among healthy adults, particularly in females. SARS-CoV-2 infection was associated with underrepresentation of IHG-I (21%) versus overrepresentation (77%) of IHG-II or IHG-IV, especially in males versus females (P < .01). Presentation with IHG-I was associated with 88% lower mortality, after controlling for age and sex; reduced risk of hospitalization and respiratory failure; lower plasma IL-6 levels; rapid clearance of nasopharyngeal SARS-CoV-2 burden; and gene expression signatures correlating with survival that signify immunocompetence and controlled inflammation. In non-COVID-19 cohorts, IR-preserving metrics were associated with resistance to progressive influenza or HIV infection, as well as lower 9-year mortality in the Framingham Heart Study, especially in females.

CONCLUSIONS:

Preservation of immunocompetence with controlled inflammation during antigenic challenges is a hallmark of IR and associates with longevity and AIDS resistance. Independent of age, a male-biased proclivity to degrade IR before and/or during SARS-CoV-2 infection predisposes to severe COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Insufficiency / T-Lymphocytes / HIV Infections / Sex Factors / HIV-1 / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: J Allergy Clin Immunol Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Insufficiency / T-Lymphocytes / HIV Infections / Sex Factors / HIV-1 / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: J Allergy Clin Immunol Year: 2021 Document Type: Article